Dr. Edward P. Gerstenfeld

Dr. Edward P. Gerstenfeld is chief of the UCSF Cardiac Electrophysiology and Arrhythmia Service. His expertise includes treating arrhythmias, or irregular heartbeats, with catheter ablation. Specific techniques, such as endocardial and epicardial ablation, may be used for atrial fibrillation, supraventricular tachycardia or ventricular tachycardia. Gerstenfeld also specializes in treating patients with inherited arrhythmia syndromes such as arrhythmogenic right ventricular cardiomyopathy, hypertrophic cardiomyopathy, Brugada syndrome, long QT syndrome and adult congenital heart disease. Treatments include implantation of pacemakers, defibrillators and cardiac resynchronization devices. In his research, Gerstenfeld studies the mechanisms of arrhythmia, new technologies for mapping and ablation of arrhythmias, biomedical signal processing and electrocardiography. He is the primary investigator for several clinical trials. Gerstenfeld earned a medical degree at Northwestern University Feinberg School of Medicine and a master of science degree in biomedical engineering at Northwestern University. He completed a residency at Beth Israel Deaconess Medical Center, a cardiology fellowship at the University of Massachusetts, a research fellowship at UCSF and an electrophysiology fellowship at the University of Pennsylvania. Gerstenfeld is a fellow of the American College of Cardiology and a member of the Heart Rhythm Society and American Heart Association. He has published numerous manuscripts and book chapters, and he often lectures on mapping and treating arrhythmias. He is associate editor of the Journal of the American College of Cardiology (JACC): Clinical Electrophysiology.

Dr. Gerstenfeld is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Arrhythmias, Atrial Fibrillation, Ventricular Tachycardia, Cardiac Ablation, and Pacemaker Implantation.

Dr. Gerstenfeld is board certified in American Board Of Internal Medicine, Clinical Cardiac Electrophysiology. He is actively involved in clinical research, co-authoring 197 peer reviewed articles and participating in 6 clinical trials. Dr. Gerstenfeld is currently accepting new patients.